Quick Answer
HCW Biologics Inc. reported Net Income of -$7.96 million for fiscal year 2025.
HCW Biologics Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$7.96M | +73.5% |
| 2024 | -$30.02M | -20.1% |
| 2023 | -$24.99M | -67.7% |
| 2022 | -$14.90M | -15.8% |
| 2021 | -$12.86M | -121.7% |
| 2020 | -$5.80M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$4.55M | -16.7% | -136.3% |
| June 30, 2025 | -$1.93M | +87.4% | +12.3% |
| March 31, 2025 | -$2.20M | +70.6% | +43.7% |
| September 30, 2024 | -$3.90M | +21.0% | +74.5% |
| June 30, 2024 | -$15.28M | -255.0% | -104.6% |
| March 31, 2024 | -$7.47M | -47.3% | -51.2% |
| September 30, 2023 | -$4.94M | -26.2% | -14.7% |
| June 30, 2023 | -$4.30M | -22.6% | +15.1% |
- HCW Biologics Inc. showed an increase of +73.5% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, HCW Biologics Inc.’s net income has declined by 37.2% (from -$5.80 million to -$7.96 million).
- The most recent figure is from HCW Biologics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: